ERBB2 and breast carcinoma: Julie K. et al. found that α-linolenic acid can reduce HER2-overexpressing breast cancer growth and demonstrated for the first time that docosahexaenoic acid (DHA) is responsible for the effects of α-linolenic acid-rich diets on HER2 signaling pathways [39].